Leerink Partnrs Has Bearish Forecast for Revvity Q3 Earnings

Key Points

• Leerink Partners has revised its Q3 2025 earnings per share estimate for Revvity from $1.25 to $1.13, reflecting a bearish outlook.
• Revvity's last reported earnings showed a net margin of 10.19% and revenue growth of 4.1% compared to the same quarter last year.
• The company recently declared a quarterly dividend of $0.07 per share, resulting in a yield of 0.30%.

Revvity Inc. (NYSE:RVTY - Free Report) - Equities research analysts at Leerink Partnrs cut their Q3 2025 earnings per share estimates for shares of Revvity in a research note issued on Monday, July 28th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings per share of $1.13 for the quarter, down from their prior forecast of $1.25. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's Q4 2025 earnings at $1.56 EPS, Q2 2026 earnings at $1.32 EPS, Q4 2026 earnings at $1.68 EPS, FY2026 earnings at $5.55 EPS and FY2027 earnings at $6.17 EPS.

Other research analysts have also issued reports about the stock. UBS Group raised shares of Revvity from a "neutral" rating to a "buy" rating and decreased their target price for the stock from $145.00 to $115.00 in a research note on Thursday, May 1st. Raymond James Financial reaffirmed an "outperform" rating and set a $115.00 price target (down previously from $120.00) on shares of Revvity in a research report on Tuesday. Evercore ISI reduced their price target on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. JPMorgan Chase & Co. reduced their price target on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 29th. Finally, Wells Fargo & Company reduced their price target on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $120.07.

Revvity Price Performance

RVTY traded up $0.30 during trading on Wednesday, reaching $88.20. The company's stock had a trading volume of 1,601,103 shares, compared to its average volume of 1,476,599. The company has a quick ratio of 2.99, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. The firm has a fifty day simple moving average of $95.54 and a two-hundred day simple moving average of $102.74. Revvity has a 1 year low of $85.80 and a 1 year high of $129.50. The company has a market cap of $10.40 billion, a price-to-earnings ratio of 37.37, a PEG ratio of 2.36 and a beta of 0.98.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%. The company had revenue of $720.28 million for the quarter, compared to analysts' expectations of $711.26 million. During the same period in the previous year, the firm posted $1.22 EPS. Revvity's revenue was up 4.1% compared to the same quarter last year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Optiver Holding B.V. acquired a new stake in Revvity during the fourth quarter worth approximately $33,000. Quarry LP boosted its holdings in shares of Revvity by 45.7% in the 4th quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after purchasing an additional 95 shares during the last quarter. UMB Bank n.a. boosted its holdings in shares of Revvity by 138.8% in the 2nd quarter. UMB Bank n.a. now owns 406 shares of the company's stock valued at $39,000 after purchasing an additional 236 shares during the last quarter. CVA Family Office LLC boosted its holdings in shares of Revvity by 79.0% in the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company's stock valued at $40,000 after purchasing an additional 181 shares during the last quarter. Finally, Vermillion Wealth Management Inc. acquired a new position in shares of Revvity in the 4th quarter valued at $41,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity's dividend payout ratio (DPR) is 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.